Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,472
datasets available to search
ShareScore release 0.9.0
Dataset results
1,472 results for “EGFR”
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR
ClinicalTrials.gov study NCT07155187. IPD Sharing: YES. Countries: 6. Publications: 0.
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
ClinicalTrials.gov study NCT06706076. IPD Sharing: UNDECIDED. Countries: 9. Publications: 0.
Different Approaches for CART-EGFR-IL13Ra2 Dosing in Recurrent GBM
ClinicalTrials.gov study NCT07209241. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Befotertinib and Icotinib for NSCLC With Uncommon EGFR Mutations
ClinicalTrials.gov study NCT06517953. IPD Sharing: YES. Countries: 1. Publications: 0.
Third-generation EGFR-TKI Plus Anlotinib as Maintenance for NSCLC With Small Cell Transformation After EGFR-TKI Resistance
ClinicalTrials.gov study NCT06634667. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Osimertinib Plus Bevacizumab in Untreated EGFR Exon21 L858R Mutated NSCLC
ClinicalTrials.gov study NCT04988607. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Befotertinib Combined Bevacizumab or Platinum-based Double Chemotherapy for Resectable Locally-advanced EGFR Mutation-positive Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT06755684. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Detection of EGFR Mutation in Malignant Pleural Effusion of Lung Cancer Patients and Cancer Cell Lines Establishment
ClinicalTrials.gov study NCT00752076. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sunvozertinib Combined With Chemotherapy for EGFRm After EGFR-TKI Treatment Failure：Phase I/II
ClinicalTrials.gov study NCT06195189. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase II Study of Afatinib as Third- or Further-line Treatment for Patients With Stage IV Bronchial Adenocarcinoma, Harboring Wild-type EGFR, Expressing the Neurotensin - Neurotensin Receptor Complex
ClinicalTrials.gov study NCT02876081. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Trial of Upfront Radiotherapy Plus Almonertinib for Epidermal Growth Factor Receptor(EGFR)-Mutant Non-small-cell Lung Cancer(NSCLC) Patients With Brain Metastases
ClinicalTrials.gov study NCT04643847. IPD Sharing: NO. Countries: 1. Publications: 0.
Icotinib and Arsenic Trioxide in Treating Non-small-cell Lung Cancer Patients With Resistance to EGFR-TKI
ClinicalTrials.gov study NCT02066870. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neratinib Tablets in the Treatment of Advanced NSCLC With Rare EGFR Mutations
ClinicalTrials.gov study NCT06029816. IPD Sharing: NO. Countries: 1. Publications: 0.
Bevacizumab Plus EGFR-TKIs in Chinese Patients With EGFR-mutant NSCLC: a Real-world Study
ClinicalTrials.gov study NCT04575415. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Europe-Japan Diagnostic Study for EGFR Testing
ClinicalTrials.gov study NCT01785888. IPD Sharing: Not stated. Countries: 8. Publications: 0.
JS111 in Patients With Advanced NSCLC Harboring EGFR Mutations
ClinicalTrials.gov study NCT06940401. IPD Sharing: NO. Countries: 1. Publications: 0.
Necitumumab and Trastuzumab in Combination With Osimertinib for the Treatment of Refractory Epidermal Growth Factor Receptor (EGFR)-Mutated Stage IV Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT04285671. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Role of Erlotinib an Epidermal Growth Factor Receptor (EGFR) Inhibitor in the Treatment of Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00570375. IPD Sharing: Not stated. Countries: 1. Publications: 0.
EGFR Mutations on ctDNA in Patients With Advanced NSCLC
ClinicalTrials.gov study NCT02623257. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Survey on the Treatment Reality of Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-positive Non-small Cell Lung Cancer(NSCLC)
ClinicalTrials.gov study NCT02475720. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.